New eczema cream studied in kids and adults – could reduce steroid use?
NCT ID NCT07014007
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a cream called RV4421B-EV0407, a medical device already sold in some countries, for mild to moderate atopic dermatitis (eczema). It includes 105 participants from 3 months old to adults, with diverse skin types. The cream is used alone or with steroid creams for up to 12 weeks. Researchers are checking how well the skin tolerates it and if it helps control eczema.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RV4421B-EV0407 cream (medical device)
What this could lead to
If successful, this could provide a well-tolerated, steroid-sparing option for managing eczema symptoms across diverse skin types and ages.
What could go wrong
This is an early-phase, open-label study with no placebo group, so results may be biased. The cream is already marketed, but long-term efficacy and safety in diverse populations are still being confirmed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Insight Research Ltd
RECRUITINGQuatre Bornes, Mauritius, 742CU001, Mauritius
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact